deltatrials
Completed NCT00005183

Apolipoprotein A-I Gene Polymorphism and Atherosclerosis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Atherosclerosis Cardiovascular Diseases Coronary Arteriosclerosis Heart Diseases
Updated 7 times since 2017 Last updated: Dec 19, 2017 Started: Dec 31, 1985 Completion: Nov 30, 1988

Listed as NCT00005183, this observational or N/A phase trial focuses on Atherosclerosis and Cardiovascular Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 7 times since 1985, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 2 earlier versions

  1. Jan 2018 — Apr 2018 [monthly]

    Completed NA

  2. Jan 2017 — Jan 2018 [monthly]

    Completed NA

    First recorded

Dec 1985

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Tufts University
Data source: Tufts University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.